Beta burst dynamics in Parkinson's disease OFF and ON dopaminergic medication.

Tinkhauser G, Pogosyan A, Tan H, Herz DM, Kühn AA, Brown P. · 2017

Read Beta burst dynamics in Parkinson's disease OFF and ON dopaminergic medication. by Tinkhauser G, Pogosyan A, Tan H, Herz DM, Kühn AA, Brown P. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5667742.txt.

Introduction

Tinkhauser and co-authors report a brain study in Brain. It examines beta bursts in Parkinson's disease. Excess beta activity marks the Parkinsonian basal ganglia. That activity comes in bursts, not a steady stream. Longer bursts track worse motor impairment. The team recorded signals from the subthalamic nucleus. Eight patients were studied during brain stimulation surgery.

Recordings ran after overnight withdrawal of levodopa. They were repeated after a levodopa dose. Burst size grew as bursts lengthened. That growth showed more nerve cells firing in step. Levodopa curbed it, favoring shorter and weaker bursts. Bursts on both sides could also sync when they overlapped. Drug state shaped burst odds as well.

Catalog record

CREATORTinkhauser G, Pogosyan A, Tan H, Herz DM, Kühn AA, Brown P.
YEAR2017
COLLECTIONPAPERS
FORMATTXT
FILE SIZE59 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5667742

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Beta burst dynamics in Parkinson’s disease OFF and ON dopaminergic medication By Gerd Tinkhauser, Alek Pogosyan, Huiling Tan, Damian M Herz, Andrea A Kühn, Peter Brown Published in: Brain : a journal of neurology DOI: 10.1093/brain/awx252 ABSTRACT Abstract Exaggerated basal ganglia beta activity (13–35 Hz) is commonly found in patients with Parkinson’s disease and can be suppressed by dopaminergic medication, with the degree of suppression being correlated with the improvement in motor symptoms. Importantly, beta activity is not continuously elevated, but fluctuates to give beta bursts. The percentage number of longer beta bursts in a given interval is positively correlated with clinical impairment in Parkinson’s disease patients. Here we determine whether the characteristics of beta bursts are dependent on dopaminergic state. Local field potentials were recorded from the subthalamic nucleus of eight Parkinson’s disease patients during temporary lead externalization during surgery for deep brain stimulation. The recordings took place with the patient quietly seated following overnight withdrawal of levodopa and after administration of levodopa. Beta bursts were defined by applying a common amplitude threshold and burst characteristics were compared between the two drug conditions. The amplitude of beta bursts, indicative of the degree of local neural synchronization, progressively increased with burst duration. Treatment with levodopa limited this evolution leading to a relative increase of shorter, lower amplitude bursts. Synchronization, however, was not limited to local neural populations during bursts, but also, when such bursts were cotemporaneous across the hemispheres, was evidenced by bilateral phase synchronization. The probability of beta bursts and the proportion of cotemporaneous bursts were reduced by levodopa. The percentage number of longer beta bursts in a given interval was positively related to motor impairment, while the opposite was true for the percentage number of short duration beta bursts. Importantly, the decrease in burst duration was also correlated with the motor improvement. In conclusion, we demonstrate that long duration beta bursts are associated with an increase in local and interhemispheric synchronization. This may compromise information coding capacity and thereby motor processing. Dopaminergic activity limits this uncontrolled beta synchronization by terminating long duration beta bursts, with positive consequences on network state and motor symptoms. Keywords: Parkinson’s disease, beta oscillations, basal ganglia, closed-loop control, levodopa INTRODUCTION Basal ganglia beta activity (13–35 Hz) is well known to be exaggerated in patients with Parkinson’s disease, and the amplitude of such activity has been linked to motor impairment (Brown, 2003) and dopaminergic tone (Jenkinson and Brown, 2011). In particular, the reduction in beta power in the local field potential (LFP) recorded in the subthalamic nucleus (STN) after administration of levodopa and during continuous high frequency deep brain stimulation (DBS) is positively correlated with improvement of motor impairment (Kühn et al., 2006, 2008, 2009; Chen et al., 2010; López-Azcárate et al., 2010; Eusebio et al., 2011; Özkurt et al., 2011; Oswal et al., 2016; Trager et al., 2016). As such, beta activity in the STN has been used as a feedback signal in amplitude-responsive closed-loop DBS, where stimulation is delivered when beta amplitude rises above a certain threshold (Little et al., 2013a) or in proportion to beta amplitude (Rosa et al., 2015, 2017). Initial, albeit acute, studies have suggested that this adaptive approach can be at least as effective as conventional, continuous DBS, while using less battery power and incurring fewer stimulation-induced side effects, such as speech impairment and dyskinesias (Little et al., 2013a, 2016a, b; Rosa et al., 2015, 2017; Pina-Fuentes et al., 2017). However, one unresolved aspect of the pathological exaggeration of beta activity in Parkinson’s disease that impacts on the delivery of adaptive DBS is whether beta activity is tonically or phasically elevated. Evidence is beginning to accrue that physiological beta activity consists of short-lived phasic bursts in basal ganglia-cortical motor circuits (Murthy and Fetz, 1992, 1996; Feingold et al., 2015) and studies in Parkinson’s disease patients undergoing DBS suggest that pathological beta activity may tend to consist of longer duration, phasic bursts (Tinkhauser et al., 2017). Adaptive DBS has therefore been suggested to selectively trim longer beta bursts leading to a redistribution of beta bursts towards shorter, more physiological, durations (Tinkhauser et al., 2017). Here we test the hypotheses that pathological beta activity consists of prolonged bursts in Parkinson’s disease, that these bursts are associated with excessive synchronization within and between basal ganglia circuits and that such bursts are abbreviated and made less frequent by treatment with the dopaminergic prodrug, levodopa, thereby contributing to improved motor function. MATERIALS AND METHODS Subjects and surgery We investigated beta bursts before and after administration of levodopa in eight patients (16 hemispheres) with advanced Parkinson’s disease undergoing DBS surgery targeting the STN (Table 1). All subjects have been previously reported (Kühn et al., 2006). They gave their written informed consent and the local ethics committee approved the study. Inclusion criteria for each hemisphere were the presence of a beta peak in the OFF levodopa condition and a minimum recording duration of 2 min of artefact-free signal. Consequently, one subject from the original study was not included. [Table: Clinical details] Experiments and recordings DBS electrodes were temporarily externalized prior to connection to the implantable pulse generator. LFP recordings were performed with the patient quietly seated following overnight withdrawal of antiparkinsonian medication before and after administration of levodopa (test challenge dose in Table 1) 3–6 days after lead implantation. In four subjects (Subjects 1, 2, 6 and 8) LFPs were also recorded during self-paced, discrete, front-and-back joystick movements; LFPs were recorded from adjacent bipolar contact pairs (01, 12, 23) and the contact pair with the highest beta power in the OFF condition was selected for further analyses. Signals were amplified and filtered at 1–250 Hz using a custom-made, high-impedance amplifier (which had at its front end input stage the INA 128 instrumentation amplifier, Texas Instruments) and recorded through a 1401 analogue/digital converter (Cambridge Electronic Design) onto a computer using Spike2 software (Cambridge Electronic Design). Signals were sampled at either 625 Hz or 1 kHz. Before and after administration of levodopa, motor symptoms were assessed using the Unified Parkinson’s Disease Rating Scale (UPDRS). Half points were used to increase the sensitivity of the test. Signal processing and determination of bursts Figure 1 and Supplementary Fig. 1 illustrate the processing steps involved in the discrimination of bursts of beta activity. After visual signal inspection and artefact removal using Spike2 Software, the data were imported into Matlab (version R 2015b; MathWorks, Natick, MA), where all further signal processing steps took place. Signal duration ranged from 136 s to 365 s with a mean signal duration of 232.0 ± 14.2 s for the OFF condition and 231.9 ± 15.5 s for the ON condition without significant difference [t(15) = 0.006, P = 0.995]. Signal durations between left and right STNs were matched in both OFF and ON conditions. [Figure: Burst determination.(A) A segment of the filtered LFP signal (5–40 Hz) and the time evolving wavelet amplitude (from the same segment) of the beta peak frequency (18 Hz) derived from the wavelet transformed signal, both for OFF (grey) and ON (blue) levodopa. The red dashed horizontal line illustrates the common amplitude threshold, which corresponds to the mean of the 75th percentile amplitudes of OFF and ON levodopa. Periods of the time

Read the complete text